61314-625 : Cimerli .5 mg/.05ml Intravitreal Injection, Solution


NDC: 61314-625
Labeler: Sandoz Inc
Product Type: Human Prescription Drug
Drug Name:  Cimerli
Dosage Form: Intravitreal Injection, Solution
Application #: BLA761165
Rev. Date: 


NDC Package Codes:

  • 61314-625-94: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (61314‑625‑94) / .05 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Ranibizumab

Dosage Strength:

  • .5 mg/.05mL

Pharmaceutical Classes:

  • Vascular Endothelial Growth Factor Inhibitor [EPC]
  • Vascular Endothelial Growth Factor Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 61314-624 Cimerli .3 mg/.05ml Intravitreal Injection, Solution by Sandoz Inc
  • 70114-440 Cimerli .3 mg/.05ml Intravitreal Injection, Solution by Coherus Biosciences Inc
  • 70114-441 Cimerli .5 mg/.05ml Intravitreal Injection, Solution by Coherus Biosciences Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 61314-625 QR Code

< Prev: 61314-624Next: 61314-628 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.